吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

未开盘 07-19 16:00:00 EDT

72.56

-0.95

-1.29%

盘后72.50

-0.06-0.08%

19:59 EDT

最高73.74	最低71.96	成交量557.18万
今开73.51	昨收73.51	日振幅2.42%
总市值903.99亿	流通市值902.20亿	总股本12.46亿
成交额4.05亿	换手率0.45%	流通股本12.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":72.56,"timestamp":1721419200000,"preClose":73.51,"halted":0,"volume":5571805,"hourTrading":{"tag":"盘后","latestPrice":72.5,"preClose":72.56,"latestTime":"19:59 EDT","volume":337028,"amount":24455204.3635,"timestamp":1721433557408},"delay":0,"floatShares":1243383927,"shares":1245853209,"eps":0.388377,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.95,"latestTime":"07-19 16:00:00 EDT","open":73.51,"high":73.74,"low":71.96,"amount":404587928.0592,"amplitude":0.024214,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.388377,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"listingDate":696056400000,"adjPreClose":73.51,"adrRate":0,"dividendRate":0.041621,"preHourTrading":{"tag":"盘前","latestPrice":73.51,"preClose":73.51,"latestTime":"09:29 EDT","volume":20738,"amount":1525804.36402,"timestamp":1721395799999},"postHourTrading":{"tag":"盘后","latestPrice":72.5,"preClose":72.56,"latestTime":"19:59 EDT","volume":337028,"amount":24455204.3635,"timestamp":1721433557408},"volumeRatio":0.8405941214648333,"impliedVol":0.2928,"impliedVolPercentile":0.7976},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2452686601","title":"吉利德科学上涨3.08%，报73.85美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452686601","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452686601?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:13","pubTimestamp":1721225613,"startTime":"0","endTime":"0","summary":"7月17日，吉利德科学(GILD)盘中上涨3.08%，截至22:13，报73.85美元/股，成交9758.6万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：8月8日，吉利德科学将于(美东)盘后披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/17221341634818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4532","IE00BSNM7G36.USD","BK4585","LU0234570918.USD","LU1066051498.USD","LU1430594728.SGD","GILD","LU0289739699.SGD","LU1585245621.USD","LU2468319806.SGD","BK4578","LU1066053197.SGD","BK4566","IE00BZ1G4Q59.USD","BK4568","LU0109394709.USD","LU1839511570.USD","LU0320765992.SGD","BK4139","BK4583","IE00BKVL7J92.USD","LU0058720904.USD","BK4550","LU2087621335.USD","BK4588","LU0889565916.HKD","LU1571399168.USD"],"gpt_icon":0},{"id":"2451691383","title":"吉利德科学上涨1.26%，报71.7美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451691383","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451691383?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:02","pubTimestamp":1721138557,"startTime":"0","endTime":"0","summary":"7月16日，吉利德科学(GILD)盘中上涨1.26%，截至22:02，报71.7美元/股，成交4071.54万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：8月8日，吉利德科学将于(美东)盘后披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/16220241608119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4568","IE00BKVL7J92.USD","LU1585245621.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","BK4532","BK4566","LU0889565916.HKD","LU2087621335.USD","LU2468319806.SGD","GILD","LU1066051498.USD","BK4578","LU0289739699.SGD","BK4588","LU1571399168.USD","LU1430594728.SGD","LU1066053197.SGD","BK4585","BK4583","BK4550","LU0320765992.SGD","LU0058720904.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2450854285","title":"TIGIT靶点命途多舛！罗氏再受挫，诺华、默沙东刹车，吉利德、GSK前景几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2450854285","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450854285?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:56","pubTimestamp":1720781795,"startTime":"0","endTime":"0","summary":"作为肿瘤治疗领域的潜力靶点，TIGIT靶点药物命途多舛的研发进程，产业始终给予高度关注。这是全球首个TIGIT III期临床失败案例。2021年底，TIGIT靶点迎来商业合作热潮。短短一个月内，3个重大的制药行业合作案例将TIGIT靶点推向了前所未有的热度。然而，随着临床试验的深入，TIGIT靶点药物的实际疗效和安全性受到更严格的检验。尽管如此，罗氏并未完全放弃对TIGIT靶点的探索。诺华、默沙东“撤退”吉利德、GSK前景几何？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4533","IE00BJT1NW94.SGD","LU1839511570.USD","BK4583","LU1037948541.HKD","LU1057294990.SGD","LU1061106388.HKD","LU1934455863.HKD","LU0320765992.SGD","IE00BLSP4239.USD","BK4007","BK4566","LU1989772840.SGD","BK4578","LU1571399168.USD","LU1066053197.SGD","BK4550","LU2468319806.SGD","LU1066051225.USD","IE00B1BXHZ80.USD","GSK.UK","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4585","LU0058720904.USD","MRK","IE000M9KFDE8.USD","BK4588","LU0289739699.SGD","LU1066051498.USD","IE0002141913.USD","LU1585245621.USD","BK4568","LU1066051811.HKD","BK4534","BK4139","LU1093756168.USD","BK4516","IE00BBT3K403.USD","GILD","BK4559","LU0208291251.USD","LU0265550359.USD","LU1989771016.USD","NVS","GSK","LU0965509283.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2450993364","title":"吉利德科学上涨1.3%，报69.641美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450993364","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450993364?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:57","pubTimestamp":1720709846,"startTime":"0","endTime":"0","summary":"7月11日，吉利德科学(GILD)盘中上涨1.3%，截至22:57，报69.641美元/股，成交1.66亿美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：7月8日，吉利德科学获Raymond James上调评级至Outperform，目标价上调至93美元。8月8日，吉利德科学将于(美东)盘后披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/11225741527035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4568","IE00BKVL7J92.USD","LU1585245621.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","BK4532","BK4566","LU0889565916.HKD","LU2087621335.USD","LU2468319806.SGD","GILD","LU1066051498.USD","BK4578","LU0289739699.SGD","BK4588","LU1571399168.USD","LU1430594728.SGD","LU1066053197.SGD","BK4585","BK4583","BK4550","LU0320765992.SGD","LU0058720904.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2450981121","title":"吉利德科学上涨1.3%，报68.64美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450981121","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450981121?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:43","pubTimestamp":1720622582,"startTime":"0","endTime":"0","summary":"7月10日，吉利德科学(GILD)盘中上涨1.3%，截至22:43，报68.64美元/股，成交4318.15万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：7月8日，吉利德科学获Raymond James上调评级至Outperform，目标价上调至93美元。8月8日，吉利德科学将于(美东)盘后披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/10224341499382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1839511570.USD","BK4583","LU0109394709.USD","LU0320765992.SGD","BK4566","BK4578","LU1571399168.USD","LU1066053197.SGD","LU0889565916.HKD","BK4550","LU2468319806.SGD","IE00BSNM7G36.USD","BK4585","BK4532","LU0058720904.USD","BK4588","LU0289739699.SGD","IE00BKVL7J92.USD","LU1066051498.USD","LU1585245621.USD","BK4568","LU1430594728.SGD","BK4139","IE00BZ1G4Q59.USD","GILD","LU2087621335.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2449726687","title":"BUZZ-券商将吉利德科学公司评级上调至 \"跑赢大盘\"，该公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2449726687","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449726687?lang=zh_cn&edition=full","pubTime":"2024-07-08 20:26","pubTimestamp":1720441603,"startTime":"0","endTime":"0","summary":"    7月8日 - ** 吉利德科学公司  股价盘前上涨3.1%至68.74美元** 经纪公司Raymond James将公司股票评级从 \"市场表现 \"上调至 \"跑赢大盘\"。** 吉利德的长效药物来那卡韦治疗艾滋病的研究数据出色，而且肝病药物塞拉得帕有望在今年晚些时候获得批准，这些因素导致了公司评级的上调。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BUZZ"],"gpt_icon":0},{"id":"2449775769","title":"泓博医药：由于辉瑞公司的战略调整，其关闭了位于英国格林威治的抗病毒业务部门，该项目未推进到临床阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2449775769","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449775769?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:02","pubTimestamp":1720436551,"startTime":"0","endTime":"0","summary":"由于辉瑞公司的战略调整，其关闭了位于英国格林威治的抗病毒业务部门，该项目未推进到临床阶段。吉利德的化合物专利与本公司的化合物专利属于不同的化学类型。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708190434958fff0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708190434958fff0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051498.USD","IE00BLSP4239.USD","LU0122379950.USD","LU0321505868.SGD","SG9999002232.USD","IE00B19Z3581.USD","BK4592","BK4585","BK4534","LU0868494617.USD","SG9999001176.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4588","LU0170899867.USD","BK4550","LU0289739699.SGD","SG9999011175.SGD","LU0321505439.SGD","SG9999001176.USD","SG9999013999.USD","SG9999003800.SGD","LU1057294990.SGD","SGXZ57979304.SGD","IE0002270589.USD","LU0456855351.SGD","LU1023059063.AUD","LU0234572021.USD","BK4533","BK4581","BK4007","GILD","LU1066053197.SGD","IE00BBT3K403.USD","LU0058720904.USD","BK4568","PFE"],"gpt_icon":0},{"id":"2448485669","title":"吉利德科学下跌1.3%，报67.51美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448485669","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448485669?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:56","pubTimestamp":1720014986,"startTime":"0","endTime":"0","summary":"7月3日，吉利德科学(GILD)盘中下跌1.3%，截至21:56，报67.51美元/股，成交1779.36万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：7月1日，吉利德科学获加拿大皇家银行重申评级Sector Perform，目标价74美元。8月1日，吉利德科学将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/03215641360978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1571399168.USD","BK4568","BK4550","LU1066051498.USD","BK4588","LU0320765992.SGD","BK4566","BK4139","BK4578","LU1585245621.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0234570918.USD","GILD","IE00BZ1G4Q59.USD","BK4532","LU0109394709.USD","LU0289739699.SGD","LU1430594728.SGD","LU2468319806.SGD","BK4585","BK4583","LU2087621335.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2448157132","title":"吉利德科学下跌1.31%，报67.74美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448157132","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448157132?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:54","pubTimestamp":1719928472,"startTime":"0","endTime":"0","summary":"7月2日，吉利德科学(GILD)盘中下跌1.31%，截至21:54，报67.74美元/股，成交2389.01万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：7月1日，吉利德科学获加拿大皇家银行重申评级Sector Perform，目标价74美元。8月1日，吉利德科学将披露2024财年中报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022158269566e9bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022158269566e9bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BSNM7G36.USD","BK4585","LU0234570918.USD","LU1066051498.USD","LU1430594728.SGD","GILD","LU0289739699.SGD","LU1585245621.USD","LU2468319806.SGD","BK4578","LU1066053197.SGD","BK4566","IE00BZ1G4Q59.USD","BK4568","LU0109394709.USD","LU1839511570.USD","LU0320765992.SGD","BK4139","BK4583","IE00BKVL7J92.USD","LU0058720904.USD","BK4550","LU2087621335.USD","BK4588","LU0889565916.HKD","LU1571399168.USD"],"gpt_icon":0},{"id":"2448697121","title":"破局100%预防艾滋“神药”，吉利德股价却开心不起来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2448697121","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448697121?lang=zh_cn&edition=full","pubTime":"2024-07-02 10:15","pubTimestamp":1719886524,"startTime":"0","endTime":"0","summary":"近期，随着备受关注的艾滋新药Lenacapavir最新试验结果获得积极进展，吉利德的股价亦闻声大涨10%，市值单日涨幅超过66亿美元。艾滋病治疗药物是吉利德营业收入的主要来源之一，2023年艾滋病治疗药物的销售额占比超过67%。2023年，吉利德抗肿瘤管线总销售额为29.32亿美元，同比增长8%;2024年第一季度，肿瘤产品销售额同比增长18%，达7.89亿美元。尽管屡屡折戟，吉利德却似乎并未放弃在抗肿瘤领域的野心。","market":"us","thumbnail":"https://static.tigerbbs.com/ea6bf0309e602c280b397fa13f206c2c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ea6bf0309e602c280b397fa13f206c2c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144110.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","IE00BZ1G4Q59.USD","BK4578","LU1066051498.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0320765992.SGD","LU0058720904.USD","LU1430594728.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","BK4139","LU0109394709.USD","LU1585245621.USD","GILD","LU1571399168.USD","LU2468319806.SGD","BK4566","LU0889565916.HKD","LU0234570918.USD","BK4550","BK4532","BK4568","BK4583","LU2087621335.USD","LU1839511570.USD"],"gpt_icon":1},{"id":"2446559156","title":"雅本化学：子公司朴颐化学与吉利德无业务往来","url":"https://stock-news.laohu8.com/highlight/detail?id=2446559156","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446559156?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:39","pubTimestamp":1719499149,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问子公司朴颐化学与吉利德是否有业务往来？是否有向吉利德供货瑞德西韦的中间体？雅本化学（300261.SZ）6月27日在投资者互动平台表示，公司子公司朴颐化学与其无业务往来。(记者 王可然)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272239499f6c493b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406272239499f6c493b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD"],"gpt_icon":0},{"id":"2446658332","title":"艾迪药业(688488.SH)：目前未与吉利德有相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2446658332","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446658332?lang=zh_cn&edition=full","pubTime":"2024-06-27 16:38","pubTimestamp":1719477514,"startTime":"0","endTime":"0","summary":"格隆汇6月27日丨艾迪药业(688488.SH)在互动平台表示，公司目前未与吉利德有相关合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716384695dd932d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062716384695dd932d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","BK4568","BK4566","LU0889565916.HKD","688488","LU0109394709.USD","BK4139","LU1571399168.USD","BK4588","GILD","LU0320765992.SGD","LU0058720904.USD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU1839511570.USD","LU2468319806.SGD","BK4583","LU0234570918.USD","LU1430594728.SGD","BK4585","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4532","LU1585245621.USD","LU1066053197.SGD","BK4578"],"gpt_icon":0},{"id":"2446824189","title":"吉利德科学下跌1.22%，报69.87美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446824189","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446824189?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:19","pubTimestamp":1719335994,"startTime":"0","endTime":"0","summary":"6月26日，吉利德科学(GILD)盘中下跌1.22%，截至01:19，报69.87美元/股，成交1.97亿美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：8月1日，吉利德科学将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/26011941191845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0058720904.USD","IE00BSNM7G36.USD","LU0234570918.USD","BK4568","LU2087621335.USD","LU1839511570.USD","GILD","LU1066053197.SGD","LU1066051498.USD","BK4588","BK4585","LU1571399168.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4578","BK4583","LU0109394709.USD","BK4566","LU0889565916.HKD","BK4550","BK4139","BK4532","LU1585245621.USD","LU2468319806.SGD","LU0320765992.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2445070539","title":"吉利德科学上涨1.25%，报71.55美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445070539","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445070539?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:10","pubTimestamp":1719238220,"startTime":"0","endTime":"0","summary":"6月24日，吉利德科学(GILD)盘中上涨1.25%，截至22:10，报71.55美元/股，成交7449.88万美元。财务数据显示，截至2024年03月31日，吉利德科学收入总额66.86亿美元，同比增长5.26%；归母净利润-41.7亿美元，同比减少512.87%。大事提醒：6月20日，吉利德科学获Robert W. Baird重申评级Neutral，目标价80美元。8月1日，吉利德科学将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/24221041171087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4568","IE00BKVL7J92.USD","LU1585245621.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","BK4532","BK4566","LU0889565916.HKD","LU2087621335.USD","LU2468319806.SGD","GILD","LU1066051498.USD","BK4578","LU0289739699.SGD","BK4588","LU1571399168.USD","LU1430594728.SGD","LU1066053197.SGD","BK4585","BK4583","BK4550","LU0320765992.SGD","LU0058720904.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2445248170","title":"诺思格(301333.SZ)：现阶段没有对抗艾滋病毒的相关研究，暂无跟吉利德的相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2445248170","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445248170?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:03","pubTimestamp":1719223406,"startTime":"0","endTime":"0","summary":"格隆汇6月24日丨诺思格(301333.SZ)在投资者互动平台表示，公司现阶段没有对抗艾滋病毒的相关研究，暂无跟吉利德的相关合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241804059f5f6162&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241804059f5f6162&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","BK4568","BK4566","LU0889565916.HKD","LU0109394709.USD","BK4139","LU1571399168.USD","BK4588","GILD","LU0320765992.SGD","LU0058720904.USD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU1839511570.USD","LU2468319806.SGD","BK4583","LU0234570918.USD","LU1430594728.SGD","BK4585","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4532","LU1585245621.USD","LU1066053197.SGD","BK4578"],"gpt_icon":0},{"id":"2445049041","title":"美国研究综述-卡马斯、礼来、微策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2445049041","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445049041?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:45","pubTimestamp":1719215146,"startTime":"0","endTime":"0","summary":"要闻             * Carmax Inc   ：加拿大皇家银行将其目标价从 73 美元上调至 75 美元             * 礼来   ：杰富瑞将目标价从994美元上调至1015美元             * 微策略公司  ：Canaccord Genuity将目标价从2047美元下调至1826美元             * Sharecare Inc   ：Canaccord Genuity将目标价从买入下调至持有             * 赛默飞世尔科技公司   ：加拿大皇家银行将目标价从662美元下调至660美元 以下是路透周一报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","PAYC","PYCR","DLR","TMUS","MPC","LNG","BK4588","LU1551013342.USD","RGEN","PSX","SHCR","LU0251142724.SGD","MSTR","T","KBH","TMO","LU0321505439.SGD","BK4581","BK4578","WAL","LLY","CYRX","SRPT","GILD","LU1989771016.USD","LU0266512127.USD","FDS","VLO","CYTK","KMX","LU0289739699.SGD","NVDA","BIO","LU1267930573.SGD","WKHS","BK4587","IE00B1BXHZ80.USD","IE00B3S45H60.SGD","QDEL","BK4579","BK4589","VZ","IE00BJT1NW94.SGD","COCH","BK4585","DAY","IFF","PCTY"],"gpt_icon":0},{"id":"2445004559","title":"吉利德科学HIV预防药成功率为100%，利空治疗药？艾迪药业回应：存量患者需要用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2445004559","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445004559?lang=zh_cn&edition=full","pubTime":"2024-06-24 14:51","pubTimestamp":1719211883,"startTime":"0","endTime":"0","summary":"6月20日，吉利德科学宣布，关键的3期PURPOSE1临床试验中期分析顶线结果显示，每年给药两次的注射用HIV-1衣壳抑制剂lenacapavir(来那卡帕韦)在针对顺性别女性的HIV预防研究中展示出100%的有效性。6月24日，A股艾滋病药物上市公司股价大跌，截至早盘收盘，艾迪药业跌超10%，前沿生物跌近5%。对此，艾迪药业相关人士表示，吉利德科学为高危暴露人群做艾滋病事前的预防，而公司为艾滋病患者做临床试验提供药物。问及未来不会有艾滋病患者时，上述人士表示，按照目前的试验结果，它可能做一定的预防，但还有大量的存量患者需要用药。（21财经）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624145123aef63c65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624145123aef63c65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU0234570918.USD","BK4550","GILD","BK4585","LU1066053197.SGD","BK4588","BK4568","IE00BZ1G4Q59.USD","LU0109394709.USD","LU1430594728.SGD","LU2468319806.SGD","LU0889565916.HKD","LU1585245621.USD","IE00BSNM7G36.USD","BK4139","LU1571399168.USD","BK4578","LU1839511570.USD","LU0058720904.USD","BK4532","BK4583","LU2087621335.USD","LU0320765992.SGD","LU0289739699.SGD","LU1066051498.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2445137970","title":"21健讯Daily｜北京通州区卫健委鼓励专家办“营利性”民营医院；吉利德HIV预防药物迎突破性进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2445137970","media":"21财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445137970?lang=zh_cn&edition=full","pubTime":"2024-06-24 11:30","pubTimestamp":1719199859,"startTime":"0","endTime":"0","summary":"北京通州区卫生健康委员会鼓励专家举办“营利性”民营医院近日，北京通州区卫生健康委员会发布了关于对《通州区社会办医疗机构设置指引》公开征求意见的公告，计划于2024年6月4日至2024年7月3日，面向全社会征集意见建议。FDA对可行走的患者授予了传统批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241131059f5e1838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241131059f5e1838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","LU0889565916.HKD","BK4585","LU0109394709.USD","LU0320765992.SGD","BK4532","LU1571399168.USD","LU1430594728.SGD","BK4566","BK4578","BK4200","GILD","BK4583","CRC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","LU0289739699.SGD","ASO","BK4139","BK4568","LU1066051498.USD","BK4213","IE00BSNM7G36.USD","BK4561","LU1839511570.USD","LU0058720904.USD","LU1066053197.SGD","LU1585245621.USD","LU2087621335.USD","LU2468319806.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2445091046","title":"美股吉利德股价大涨，预防HIV新药取得重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2445091046","media":"中金在线","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445091046?lang=zh_cn&edition=full","pubTime":"2024-06-24 09:33","pubTimestamp":1719192812,"startTime":"0","endTime":"0","summary":"美股吉利德股价大涨，预防HIV新药取得重大突破。美国生物制药公司 吉利德科学 股价上涨3.18%，近两个交易日累计大涨近12%。该公司近日宣布，其研发的“Lenacapavir”在预防艾滋病毒方面显示出了100%的有效性。最新公布的是一项名为“PURPOSE 1”的3期双盲随机研究试验，旨在评估其对南非25个站点和乌干达3个站点的5300多名6岁至25岁女性的安全性和有效性。结果显示，在Lenacapavir组2134名女性中，HIV感染病例为0例。相关个股： 艾迪药业 (688488) 、 前沿生物 (688221)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062409493495d09633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062409493495d09633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU1839511570.USD","LU1066053197.SGD","LU0058720904.USD","BK4588","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4139","LU1571399168.USD","GILD","BK4566","IE00BSNM7G36.USD","LU0289739699.SGD","BK4532","BK4568","BK4550","BK4583","LU2087621335.USD","BK4585","LU1585245621.USD","LU2468319806.SGD","LU0234570918.USD","LU1066051498.USD","IE00BKVL7J92.USD","BK4578"],"gpt_icon":0},{"id":"2445710413","title":"吉利德每年给药两次的长效HIV注射药物有效率达100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445710413","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445710413?lang=zh_cn&edition=full","pubTime":"2024-06-22 09:51","pubTimestamp":1719021069,"startTime":"0","endTime":"0","summary":"吉利德科学公布了旗下艾滋病在研药物lenacapavir(利那卡韦)的大型后期临床试验中期分析顶线结果，数据显示，每年给药两次的注射用lenacapavir在顺性别女性的HIV预防研究中展示出100%的有效性。这项称为PURPOSE1的关键性3期试验达到了其关键疗效终点，每年给药两次的lenacapavir，效果优于需每日口服的舒发泰(恩曲他滨200mg/富马酸替诺福韦二吡呋酯300mg，F/TDF)。据此，独立数据监测委员会(DMC)建议吉利德提前停止试验的盲性阶段(blinded phase)，并向所有受试者提供开放标签lenacapavir。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062209552995cb085f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062209552995cb085f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1585245621.USD","LU0320765992.SGD","LU2087621335.USD","BK4568","LU2468319806.SGD","GILD","LU0234570918.USD","LU0289739699.SGD","BK4588","LU1571399168.USD","BK4585","LU1066053197.SGD","IE00BKVL7J92.USD","LU0109394709.USD","BK4566","BK4532","LU1839511570.USD","LU1430594728.SGD","BK4578","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1066051498.USD","IE00BSNM7G36.USD","BK4550","LU0058720904.USD","BK4583","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0372},{"period":"1month","weight":0.149},{"period":"3month","weight":0.0869},{"period":"6month","weight":-0.1687},{"period":"1year","weight":-0.0923},{"period":"ytd","weight":-0.1043}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.041198},{"month":2,"riseRate":0.393939,"avgChangeRate":0.002047},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.009403},{"month":4,"riseRate":0.545455,"avgChangeRate":0.013826},{"month":5,"riseRate":0.545455,"avgChangeRate":0.020012},{"month":6,"riseRate":0.636364,"avgChangeRate":0.026233},{"month":7,"riseRate":0.545455,"avgChangeRate":0.014644},{"month":8,"riseRate":0.53125,"avgChangeRate":0.033833},{"month":9,"riseRate":0.5625,"avgChangeRate":0.031735},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00096},{"month":11,"riseRate":0.625,"avgChangeRate":0.039318},{"month":12,"riseRate":0.40625,"avgChangeRate":0.011587}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}